Literature DB >> 8277111

The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting.

T D Pickering1, J H Gurwitz, D Zaleznik, J P Noonan, J Avorn.   

Abstract

OBJECTIVE: To evaluate the appropriateness of ciprofloxacin-prescribing in the long-term care setting.
DESIGN: Retrospective chart review.
SETTING: A large academically oriented long-term care facility. PATIENTS: Institutionalized elderly patients with a mean age of 88 years.
METHODS: One hundred orders were randomly selected for review from all ciprofloxacin orders initiated over a 3-year period. Criteria for appropriateness of ciprofloxacin-prescribing were developed based on a comprehensive review of the medical literature. Evaluation of appropriateness of prescribing was based on the indication for therapy and the availability of more effective and/or less expensive alternative antibiotic regimens. Only information available to the physician at the time of the order was used to judge appropriateness. Abstracted medical records were evaluated independently by a geriatrician and an infectious diseases specialist.
RESULTS: With respect to site of infection, the urinary tract accounted for 43% of all ciprofloxacin orders; the lower respiratory tract, 28%; and skin and soft-tissue infections, 17%. Only 25% of orders were judged appropriate. Twenty-three percent of orders were judged less than appropriate based on indication, and 49% due to the availability of a more effective and/or less expensive alternative antibiotic choice. There was insufficient information in the medical record to judge 3% of the orders.
CONCLUSION: These results indicate less than optimal prescribing of oral fluoroquinolones in the long-term care setting, with potential consequences including the development of resistant bacterial strains and increased health care costs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8277111     DOI: 10.1111/j.1532-5415.1994.tb06069.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

1.  Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice.

Authors:  L E Nicolle
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

Review 2.  Nursing home-acquired pneumonia. Treatment options.

Authors:  T J Marrie; K L Slayter
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

3.  Characteristics of nursing homes with comprehensive antibiotic stewardship programs: Results of a national survey.

Authors:  Caroline J Fu; Elise Mantell; Patricia W Stone; Mansi Agarwal
Journal:  Am J Infect Control       Date:  2019-08-22       Impact factor: 2.918

Review 4.  The cost of inappropriate use of anti-infective agents in older patients.

Authors:  J P Rho; T T Yoshikawa
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

5.  Variability in prescription drug utilization: issues for research.

Authors:  A H Anis; S G Carruthers; A O Carter; J Kierulf
Journal:  CMAJ       Date:  1996-03-01       Impact factor: 8.262

6.  Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia.

Authors:  Susan L Mitchell; Michele L Shaffer; Mark B Loeb; Jane L Givens; Daniel Habtemariam; Dan K Kiely; Erika D'Agata
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

7.  Patterns of antimicrobial use for respiratory tract infections in older residents of long-term care facilities.

Authors:  Paschalis Vergidis; Davidson H Hamer; Simin N Meydani; Gerard E Dallal; Tamar F Barlam
Journal:  J Am Geriatr Soc       Date:  2011-05-03       Impact factor: 5.562

8.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

9.  Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.

Authors:  Aurora Pop-Vicas; E Tacconelli; Stefan Gravenstein; Bing Lu; Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

10.  The study of pathogen resistance and antimicrobial use in dementia: study design and methodology.

Authors:  Susan L Mitchell; Michele L Shaffer; Dan K Kiely; Jane L Givens; Erika D'Agata
Journal:  Arch Gerontol Geriatr       Date:  2012-08-25       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.